Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

• Main Authors: Idris Nasir Abdullahi (Author), Anthony Uchenna Emeribe (Author), Hafeez Aderinsayo Adekola (Author), Sharafudeen Dahiru Abubakar (Author), Amos Dangana (Author), Halima Ali Shuwa (Author), Sunday Theophilus Nwoba (Author), Jelili Olaide Mustapha (Author), Muyideen Titilope Haruna (Author), Kafayat Adepeju Olowookere (Author), Olawale Sunday Animasaun (Author), Charles Egede Ugwu (Author), Solomon Oloche Onoja (Author), Abdullahi Sani Gadama (Author), Musa Mohammed (Author), Isa Muhammad Daneji (Author), Dele Ohinoyi Amadu (Author), Peter Elisha Ghamba (Author), Nkechi Blessing Onukegbe (Author), Muhammad Sagir Shehu (Author), Chiladi Isomah (Author), Adamu Babayo (Author), Abdurrahman El-Fulaty Ahmad (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measur...